SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001161697-09-000582
Filing Date
2009-06-18
Accepted
2009-06-18 15:03:10
Documents
6
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F FOR 12-31-2008 form20f.htm 20-F 589208
2 GRAPHIC fandi.jpg GRAPHIC 932
3 GRAPHIC lake.jpg GRAPHIC 1774
4 GRAPHIC lakelogo.jpg GRAPHIC 5168
5 CERTIFICATION PURSUANT TO RULE 13A-14(A) ex121.htm EX-12 12697
6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 ex131.htm EX-13 3918
  Complete submission text file 0001161697-09-000582.txt   618923
Mailing Address RM A, 22/F, NOBLE CTR, 3RD FU ZHONG RD FU TIAN DISTRICT, GUANG DONG PROVINCE SHEN ZHEN F4 NONE
Business Address RM A, 22/F, NOBLE CTR, 3RD FU ZHONG RD FU TIAN DISTRICT, GUANG DONG PROVINCE SHEN ZHEN F4 NONE 85222550688
CHINA PHARMACEUTICALS INTERNATIONAL CORP (Filer) CIK: 0001081823 (see all company filings)

IRS No.: 980348508 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-28879 | Film No.: 09898735
SIC: 7389 Services-Business Services, NEC